Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $34.7600 (-1.89%) ($34.7600 - $34.7600) on Fri. Mar. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.75% (three month average) | RSI | 33 | Latest Price | $34.7600(-1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -6.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(47%) XBI(43%) ARKG(42%) IWO(41%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.875% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-11%) TBT(-6%) UNG(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.875% (StdDev 3.75%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $9.24(-73.42%) | Inflection Point | Yes | Resistance Level | $38.58 | 5 Day Moving Average | $34.05(2.09%) | 10 Day Moving Average | $34.49(0.78%) | 20 Day Moving Average | $38.58(-9.9%) | To recent high | -33.9% | To recent low | 9.7% | Market Cap | $5.09b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |